Recursion Pharmaceuticals, Inc. Class A Common Stock
Symbol: RXRX (NASDAQ)
5.76
▼ (-5.81%) -0.355
Company Description:
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
Key Stats
- Today's Open: $6.07
- Today's High: $6.295
- Today's Low: $5.595
- Today's Volume: 44.87M
- Yesterday Close: $6.11
- Yesterday High: $6.6983
- Yesterday Low: $6
- Yesterday Volume: 58.24M
- Last Min Volume: 625
- Last Min High: $5.755
- Last Min Low: $5.755
- Last Min VWAP: $5.755
Company Profile
- Name: Recursion Pharmaceuticals, Inc. Class A Common Stock
- Website: https://www.recursion.com
- Listed Date: 2021-04-16
- Location: SALT LAKE CITY, UT
- Market Status: Active
- CIK Number: 0001601830
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $2.67B
- Round Lot: 100
- Outstanding Shares: 436.55M
- Asset Type: CS
RECENT FILINGS FOR RXRX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-10 | 4 | View |
| 2025-10-10 | 144 | View |
| 2025-10-03 | 4 | View |
| 2025-10-03 | 4 | View |
| 2025-09-26 | 4 | View |
| 2025-09-25 | 144 | View |
| 2025-09-17 | 4 | View |
| 2025-09-12 | 4 | View |
| 2025-09-10 | 144 | View |
| 2025-08-29 | 8-K/A | View |
| 2025-08-29 | 424B7 | View |
| 2025-08-28 | 4 | View |
| 2025-08-26 | 144 | View |
| 2025-08-19 | 4 | View |
| 2025-08-19 | 4 | View |
| 2025-08-19 | 4 | View |
| 2025-08-18 | 144 | View |
| 2025-08-13 | 4 | View |
| 2025-08-11 | 144 | View |
| 2025-08-05 | 10-Q | View |
Latest News on RXRX